• Aung Naing
  • Joud Hajjar

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 995)

Table of contents

  1. Front Matter
    Pages i-viii
  2. Isabella C. Glitza Oliva, Rana Alqusairi
    Pages 43-63
  3. Luis Corrales, Katherine Scilla, Christian Caglevic, Ken Miller, Julio Oliveira, Christian Rolfo
    Pages 65-95
  4. Lucia Masarova, Hagop Kantarjian, Farhad Ravandi, Padmanee Sharma, Guillermo Garcia-Manero, Naval Daver
    Pages 97-116
  5. Anisha B. Patel, Omar Pacha
    Pages 117-129
  6. Akash Jain, Vickie R. Shannon, Ajay Sheshadri
    Pages 131-149
  7. Yun Tian, Hamzah Abu-Sbeih, Yinghong Wang
    Pages 151-157
  8. Yun Tian, Hamzah Abu-Sbeih, Yinghong Wang
    Pages 159-164

About this book


The second edition of Immunotherapy is an updated overview of immuno-oncology in acute myleloid leukemia, non-small cell lung cancer and sarcomas, showcasing advances in the management of cancer broadly classified as hematological malignancies, solid tumors and tumors arising in the connective tissue. Scientists, oncologists and advanced students will be provided with knowledge of basic immunology in the context of tumor biology, providing a comprehensive overview of the cellular components of the immune system that interact with each other to provide a successful immune response. A number of new, scientific findings in his fast moving field have necessitated a thoroughly updated and revised edition including the use of immunotherapy for gastrointestinal and genitourinary cancers, as well as discussions on optimizing radiotherapy with immunotherapeutic approaches, biomarkers of response or resistance to immunotherapy, cancer imaging in immunotherapy, skin reactions to immune checkpoint inhibitors and more.

As immunotherapeutic agents differ significantly from chemotherapeutic agents in response patterns and toxicity profiles, evaluating their safety and efficacy in clinical trials remains a challenge. The new edition will discuss the use of a variety of traditional and new immunotherapy criteria to evaluate response, their inadequacies and clinical implications. Additionally, the book will outline how new advances in medical imaging technology has the potential to provide high-dimensional data to improve decision support and individualize treatment selection and monitoring.

Edited by two renowned experts in the field, the book’s chapters are written by a diverse cast of experts conducting cutting-edge research, providing the reader with the most up-to-date science.


Immunotherapy Translational cancer immunology Vaccine IL-10 ImmunoOncology

Editors and affiliations

  • Aung Naing
    • 1
  • Joud Hajjar
    • 2
  1. 1.MD Anderson Cancer CenterUniversity of TexasHoustonUSA
  2. 2.Baylor College of MedicineTexas Children’s HospitalHoustonUSA

Bibliographic information

  • DOI
  • Copyright Information Springer Nature Switzerland AG 2018
  • Publisher Name Springer, Cham
  • eBook Packages Biomedical and Life Sciences
  • Print ISBN 978-3-030-02504-5
  • Online ISBN 978-3-030-02505-2
  • Series Print ISSN 0065-2598
  • Series Online ISSN 2214-8019
  • Buy this book on publisher's site
Industry Sectors
Consumer Packaged Goods